Edward Myles

2017

In 2017, Edward Myles earned a total compensation of $1.3M as Chief Financial Officer, Executive Vice President of Finance and Treasurer at AMAG Pharmaceuticals, a 2% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$216,113
Option Awards$224,392
Salary$428,847
Stock Awards$402,150
Other$8,100
Total$1,279,602

Myles received $428.8K in salary, accounting for 34% of the total pay in 2017.

Myles also received $216.1K in non-equity incentive plan, $224.4K in option awards, $402.2K in stock awards and $8.1K in other compensation.

Rankings

In 2017, Edward Myles' compensation ranked 7,794th out of 14,666 executives tracked by ExecPay. In other words, Myles earned more than 46.9% of executives.

ClassificationRankingPercentile
All
7,794
out of 14,666
47th
Division
Manufacturing
2,919
out of 5,768
49th
Major group
Chemicals And Allied Products
949
out of 2,074
54th
Industry group
Drugs
736
out of 1,730
58th
Industry
Pharmaceutical Preparations
575
out of 1,329
57th
Source: SEC filing on April 25, 2018.

Myles' colleagues

We found four more compensation records of executives who worked with Edward Myles at AMAG Pharmaceuticals in 2017.

2017

William Heiden

AMAG Pharmaceuticals

Chief Executive Officer

2017

Nicholas Grund

AMAG Pharmaceuticals

Chief Commercial Officer

2017

Julie Krop

AMAG Pharmaceuticals

Chief Medical Officer

2017

Joseph Vittiglio

AMAG Pharmaceuticals

General Counsel

News

You may also like